关注
Eric Fagerberg
Eric Fagerberg
Graduate Student, Yale University
在 yale.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
C Cui, J Wang, E Fagerberg, PM Chen, KA Connolly, M Damo, ...
Cell 184 (25), 6101-6118. e13, 2021
2482021
A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response
KA Connolly, M Kuchroo, A Venkat, A Khatun, J Wang, I William, ...
Science immunology 6 (64), eabg7836, 2021
1782021
Modulation of let-7 miRNAs controls the differentiation of effector CD8 T cells
AC Wells, KA Daniels, CC Angelou, E Fagerberg, AS Burnside, ...
Elife 6, e26398, 2017
812017
A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma
B Fitzgerald, KA Connolly, C Cui, E Fagerberg, DL Mariuzza, NI Hornick, ...
Cell reports methods 1 (5), 2021
222021
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens
M Damo, NI Hornick, A Venkat, I William, K Clulo, S Venkatesan, J He, ...
Nature 619 (7968), 151-159, 2023
202023
Survival of Naïve T cells requires the expression of Let-7 miRNAs
EL Pobezinskaya, AC Wells, CC Angelou, E Fagerberg, E Aral, E Iverson, ...
Frontiers in immunology 10, 955, 2019
142019
A reservoir of stem-like CD8 (+) T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836
KA Connolly, M Kuchroo, A Venkat, A Khatun, J Wang, I William, ...
112021
Mapping the gene space at single-cell resolution with gene signal pattern analysis
A Venkat, S Leone, SE Youlten, E Fagerberg, J Attanasio, NS Joshi, ...
bioRxiv, 2023.11. 26.568492, 2023
12023
Intestinal tuft cell immune privilege enables norovirus persistence
MS Strine, E Fagerberg, PW Darcy, GM Barrón, RB Filler, MM Alfajaro, ...
Science Immunology 9 (93), eadi7038, 2024
2024
Abstract C101: Comprehensive identification of novel therapeutic targets for treatment of PD-1 resistant solid tumors via a genome-scale CRISPR/Cas9 in vivo T-cell screen
IL Mercier, JJ Merkin, S Keegan, C Calnan, AF Hohmann, N Colletti, ...
Molecular Cancer Therapeutics 18 (12_Supplement), C101-C101, 2019
2019
Comprehensive Identification of Novel Therapeutic Targets for Treatment of PD-1 Resistant Solid Tumors via a Genome-Scale CRISPR/Cas9 in vivo T-cell Screen
I Le Mercier, JJ Merkin, S Keegan, C Calnan, AF Hohmann, N Colletti, ...
MOLECULAR CANCER THERAPEUTICS 18 (12), 2019
2019
An Immune-CRISPRomics platform enabling genome-scale and pair-wise combination in vivo T-cell function screens enables comprehensive identification of novel therapeutic targets
I Le Mercier, JJ Merkin, S Keegan, C Calnan, AF Hohmann, N Colletti, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–12